BeStock  
Stocks › Medical Devices › GKOS

Glaukos GKOS

US equityMarket cap rank #1152Medical Devices
$237.31 −$0.79 (-0.33%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $237.31 0.00%
Open$238.87
Prev close$238.10
Day range$233.40 – $244.55
Volume1.09M
Market cap$14.05B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$211.03M+58.0% YoY
Operating profit$828,000.00+105.1% YoY
Net profit$2.02M+112.4% YoY
Diluted EPS$0.03+110.7% YoY
Free cash flow$36.49M+411.2% YoY
Operating cash flow$38.57M

Revenue, last 8 quarters

$105.5MDec '24$106.7MMar '25$124.1MJun '25$133.5MSep '25$143.1MDec '25$150.6MMar '26$185.6MJun '26$211.0MSep '26

Net profit, last 8 quarters

$-33.6MDec '24$-18.1MMar '25$-19.7MJun '25$-16.2MSep '25$-133.7MDec '25$-19.8MMar '26$-18.4MJun '26$2.0MSep '26

Diluted EPS by quarter

-0.60Dec '24-0.32Mar '25-0.34Jun '25-0.28Sep '25-2.32Dec '25-0.34Mar '26-0.31Jun '260.03Sep '26

Free cash flow by quarter

$-1.2MDec '24$-20.5MMar '25$5.8MJun '25$-11.7MSep '25$-12.7MDec '25$-16.5MMar '26$12.1MJun '26$36.5MSep '26

Annual revenue

$225.0MFY20$294.0MFY21$282.9MFY22$314.7MFY23$383.5MFY24$507.4MFY25

Profitability & balance sheet

Gross margin64.8%
Operating margin-25.3%
Net margin-24.6%
Return on equity-22.8%
Return on assets-17.2%
Return on invested capital-20.6%
Current ratio4.57
Liabilities / assets26.8%
Cash & investments$336.70M
Total debt$101.98M
Net cash (debt)$234.72M
Free cash flow / sales2.8%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Glaucoma$151.99M 72.0%
  • Corneal Health$59.04M 28.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $211.03M $185.61M $150.57M $507.44M $143.12M
Total Operating Revenue $211.03M $185.61M $150.57M $507.44M $143.12M
Cost of Revenue $31.16M $34.02M $33.34M $224.68M $144.64M
Gross Profit $179.87M $151.59M $117.23M $282.76M -$1.52M
Operating Expense $179.04M $167.36M $137.09M $482.36M $138.35M
Selling and Admin Expenses $130.94M $116.06M $92.94M $331.75M $94.70M
Research & Development $48.10M $51.30M $44.15M $150.61M $43.65M
Operating Profit $828,000.00 -$15.77M -$19.86M -$199.60M -$139.87M
Net Non-Operating Interest Income (Expense) $1.41M $820,000.00 $1.31M $6.08M $1.37M
Non-Operating Interest Income $2.49M $2.28M $2.43M $10.71M $2.51M
Non-Operating Interest Expense $1.09M $1.46M $1.13M $4.64M $1.15M
Other Income (Expense) $87,000.00 -$2.77M -$749,000.00 $479,000.00 -$1.31M
Special Income (Charges) $0.00 -$1.50M – $0.00 $0.00
Other Non-Operating Income (Expenses) $87,000.00 -$1.27M -$749,000.00 $479,000.00 -$1.31M
Pretax Profit $2.32M -$17.72M -$19.30M -$193.04M -$139.82M
Tax $303,000.00 $656,000.00 $484,000.00 -$5.35M -$6.16M
Net Profit $2.02M -$18.38M -$19.78M -$187.69M -$133.66M
Profit from Continuing Operations $2.02M -$18.38M -$19.78M -$187.69M -$133.66M
Net Income to Parent Company $2.02M -$18.38M -$19.78M -$187.69M -$133.66M
Net Income to Common Stockholders $2.02M -$18.38M -$19.78M -$187.69M -$133.66M
Basic EPS $0.03 -$0.31 -$0.34 -$3.28 -$2.32
Diluted EPS $0.03 -$0.31 -$0.34 -$3.28 -$2.32
-Less:Other Special Charges – $1.50M – – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $979.53M $920.52M $893.33M $893.49M $893.49M
Total Current Assets $579.65M $515.78M $485.75M $474.98M $474.98M
Cash and Cash Equivalents & Short-Term Investments $336.70M $286.23M $276.69M $278.76M $278.76M
-Cash and Cash Equivalents $162.33M $114.49M $104.25M $90.81M $90.81M
-Short Term Investments $174.37M $171.74M $172.44M $187.95M $187.95M
Receivables $150.00M $138.90M $119.69M $108.61M $108.61M
-Accounts Receivable $150.00M $138.90M $119.69M $108.61M $108.61M
Inventory $61.03M $59.31M $62.38M $63.56M $63.56M
Other Current Assets $31.92M $31.35M $26.99M $24.05M $24.05M
Total Non-Current Assets $399.88M $404.74M $407.57M $418.50M $418.50M
Net PPE $180.46M $181.58M $182.26M $184.18M $184.18M
-Gross PPE $180.46M $181.58M $182.26M $239.72M $239.72M
Goodwill and Other Intangible Assets $187.97M $193.86M $199.74M $208.63M $208.63M
-Goodwill $66.71M $66.71M $66.71M $66.71M $66.71M
-Other Intangible Assets $121.26M $127.15M $133.03M $141.92M $141.92M
Other Non-Current Assets $31.45M $29.30M $25.58M $25.69M $25.69M
Total Liabilities $262.26M $238.04M $222.40M $237.33M $237.33M
Total Current Liabilities $126.73M $102.33M $89.42M $101.28M $101.28M
Payables $28.50M $22.99M $23.06M $27.72M $27.72M
-Accounts Payable $24.41M $19.14M $19.15M $24.62M $24.62M
-Total Tax Payable $4.09M $3.85M $3.91M $3.09M $3.09M
Current Accrued Expenses $75.17M $57.96M $52.60M $45.43M $45.43M
Total Non-Current Liabilities $135.53M $135.71M $132.98M $136.06M $136.06M
Long Term Debt and Capital Lease Obligation $101.98M $102.84M $103.06M $103.88M $103.88M
-Long Term Capital Lease Obligation $101.98M $102.84M $103.06M $103.88M $103.88M
Non-Current Deferred Liabilities $441,000.00 $441,000.00 $441,000.00 $441,000.00 $441,000.00
Other Non-Current Liabilities $33.11M $32.43M $29.49M $31.74M $31.74M
Total Equity $717.27M $682.49M $670.93M $656.16M $656.16M
Stockholders' Equity $717.27M $682.49M $670.93M $656.16M $656.16M
Capital Stock $59,000.00 $59,000.00 $58,000.00 $58,000.00 $58,000.00
-Common Stock $59,000.00 $59,000.00 $58,000.00 $58,000.00 $58,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.68B $1.65B $1.62B $1.59B $1.59B
Retained Earnings -$969.27M -$971.29M -$952.91M -$933.13M -$933.13M
Less: Treasury Stock -$132,000.00 -$132,000.00 -$132,000.00 -$132,000.00 -$132,000.00
Gains/Losses Not Affecting Retained Earnings $1.79M $2.38M $2.64M $3.30M $3.30M
-Accumulated Depreciation – – – -$55.54M -$55.54M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $38.57M $14.82M -$12.53M -$14.79M $6.84M
Net cash flow from continuing operations $38.57M $14.82M -$12.53M -$14.79M $6.84M
Net Income from Continuing Operations $2.02M -$18.38M -$19.78M -$187.69M -$133.66M
Gain/Loss from Continuing Operations -$146,000.00 $1.18M $677,000.00 -$1.18M $1.05M
Depreciation & Depletion & Amortization $10.03M $10.14M $12.88M $42.35M $13.23M
Deferred Tax $0.00 $0.00 $0.00 -$6.49M -$6.48M
Other Non-Cash Items $14.78M $2.94M -$2.25M $1.78M $654,000.00
Change in Working Capital -$7.18M -$11.19M -$23.83M -$48.02M -$2.13M
-Change in Receivables -$9.95M -$19.45M -$12.46M -$53.02M -$10.24M
-Change in Inventory -$1.85M $1.55M $832,000.00 -$7.70M -$3.96M
-Change in Prepaid Assets -$2.97M -$5.68M -$2.01M -$6.12M -$352,000.00
-Change in Payables and Accrued Expense $9.52M $12.39M -$10.19M $18.82M $11.14M
Net cash flow from investing -$5.54M -$5.31M $10.50M -$77.61M -$15.89M
Net Cash Flow from Continuing Investing Activities -$5.54M -$5.31M $10.50M -$77.61M -$15.89M
Net PPE Purchase and Sale -$2.08M -$2.74M -$3.96M -$24.27M -$19.52M
Net Business Purchase and Sale $0.00 – – -$12.44M $0.00
Net Investment Purchase and Sale -$2.86M $1.32M $14.46M -$35.35M -$12.18M
Net Other Investing Changes -$598,000.00 – – -$5.55M -$800,000.00
Financing Cash Flow $14.69M $991,000.00 $15.77M $11.89M $2.43M
Net Cash Flow from Continuing Financing Activities $14.69M $991,000.00 $15.77M $11.89M $2.43M
Net Issuance Payments Of Debt -$355,000.00 -$336,000.00 -$304,000.00 -$1.12M -$300,000.00
Proceeds from Stock Option Exercised $15.59M $4.10M $21.71M $21.14M $2.92M
Net Other Financing Charges -$551,000.00 -$2.77M -$5.64M -$8.13M -$189,000.00
Ending Cash Balance $165.44M $117.60M $108.08M $94.65M $94.65M
Net Change in Cash $47.71M $10.51M $13.75M -$80.52M -$6.62M
Beginning Cash Balance $117.60M $108.08M $94.65M $174.36M $102.08M
Effect of Exchange Rate Changes $128,000.00 -$991,000.00 -$311,000.00 $804,000.00 -$813,000.00
Free Cash Flow $36.49M $12.09M -$16.49M -$39.06M -$12.68M

Discussion

No comments yet — be the first to weigh in on GKOS.

Sign in to join the discussion.

Scroll to Top